6550--LAB - Blood Culture Detection, Identification, And Antimicrobial Susceptibility Testing | 04/01/2026 through 03/31/2031
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the James J. Peters Veterans Affairs Medical Center, has issued a Special Notice of its intent to award a sole-source, firm fixed-price contract to Biomerieux Inc. for Blood Culture Detection, Identification, and Antimicrobial Susceptibility Testing. This is a logical follow-on contract to ensure continuity of patient care at multiple VA Medical Centers. Responses for future procurement source determination are due by February 12, 2026.
Scope of Work
This contract will cover the provision of essential consumables and supplies required for Blood Culture Detection, Identification, and Antimicrobial Susceptibility Testing. It also includes support for contractor-owned equipment currently on-site at the specified VA facilities, facilitating cost-per-kit (CPK) services. VA personnel utilize this equipment and these consumables for in-house testing.
Contract & Timeline
- Contract Type: Sole-Source, Firm Fixed-Price
- Period of Performance: April 1, 2026, through March 31, 2031 (following the expiration of the current contract on March 31, 2026)
- Locations: James J. Peters (Bronx) VAMC, East Orange VAMC (NJ), Margaret Cochran Corbin VA Campus, and Northport VAMC.
- NAICS Code: 334516 (Diagnostic Product Manufacturing)
- Small Business Standard: 1,000 employees
- Published Date: February 6, 2026
Submission & Evaluation
This notice is not a request for competitive proposals, and no solicitation will be made available. Any responses received by COB February 12, 2026, will be considered solely for the purpose of determining sources for future procurements. The Government will not compensate for any information submitted, and submission is strictly voluntary.
Eligibility / Set-Aside
This is a sole-source award to Biomerieux Inc., justified as a logical follow-on to avoid interruption to patient care. There is no competitive set-aside for this specific requirement.
Additional Notes
This is the only notice of the Government's intent to solicit, negotiate, and award to a single source for this requirement.